DermTech Melanoma Test
Commercial- Indications
- Melanoma
Company intelligence / Profile preview
DermTech
San Diego, California, United Statesdermtech.com ↗
- Ownership
- Public · DMTK
- Development stage
- Commercial
01
Overview
DermTech commercialized a non-invasive genomic test—the DermTech Melanoma Test—using its proprietary Smart Sticker technology to collect skin cells painlessly. The test analyzes RNA and DNA markers associated with melanoma, specifically LINC00518 and PRAME. It demonstrates a negative predictive value of approximately 99%, meaning it reliably rules out melanoma when the result is negative. Additional pipeline products include tests for non-melanoma skin cancers ("Carcinome") and UV damage ("Luminate"), both at earlier stages.
- Therapeutic areas
- OncologyDermatology
- Modalities
- DeviceGenomic testRNA analysisDNA analysisPrecision biomarker platform
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Collaborations with genomics, medicine, biotechnology companies; specific partners not named in provided sources.
04
Financials
- Market cap
- $3.3M
- Total revenue
- $3.8M
- Enterprise value
- $18M
Beyond the preview
Go deeper on DermTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DermTech.